
# Evidence-Based Technical Analysis - Verdict & Corrections


Yes. I audited this **against the previous architecture and the statistical principles behind each stage**, rather than assuming your revised version is correct.

My verdict:

> **Your revised architecture is stronger than the previous one, but I would NOT accept it exactly as written.**
>
> With **3 important corrections**, it becomes the stronger architecture I would use.

The biggest improvement is that you've correctly promoted **Calibration and Discrimination to sibling requirements** and recognized that **regrouping/recalibration is itself part of the research/search process**.

---

# 1. Your revised architecture — stage by stage

You proposed:

```text
Trial ledger
        ↓
Multiple-testing correction
        ↓
Calibration + Discrimination
        ↓
Permutation / Reality Check / SPA
        ↓
Strict OOS
        ↓
Forward validation
```

Let's audit each layer.

---

## ① Trial ledger

> **Every parameter variant + every regrouping/recalibration attempt**

### Verdict: ✅ Strong and correct

This is actually an important improvement over the previous version.

If you do:

```text
Strategy V1
Strategy V2
Threshold 30
Threshold 35
Threshold 40
Regime filter A
Regime filter B
Probability recalibration A
Probability recalibration B
Group by time
Group by volatility
...
```

all of those are **research decisions**.

They shouldn't magically disappear from the statistical accounting just because they aren't called "parameters."

This is exactly the right philosophy:

> **The research process itself is part of the multiple-testing problem.**

One nuance:

You don't necessarily need to count every *mere thought or inspection*. You need to count **candidate configurations/evaluations that materially participate in selection based on the data**.

That's the practical definition I'd implement.

---

# 2. Multiple-testing correction

You wrote:

> Deflated Sharpe / PBO — applied to whatever final metric you trust

### Verdict: 🟡 Correct direction, but terminology needs tightening

This is the first place I'd modify your architecture.

**Deflated Sharpe Ratio (DSR) and PBO aren't interchangeable generic "multiple-testing corrections."**

They answer somewhat different questions.

### DSR

DSR attempts to adjust the interpretation of an observed Sharpe ratio for things such as:

* multiple trials
* non-normality
* sample length
* variance in Sharpe estimates
* expected maximum Sharpe under selection

So it is appropriate when **Sharpe is actually your evaluation statistic**.

But if your trusted metric is:

```text
expectancy
profit factor
utility
max drawdown-adjusted return
calibration score
etc.
```

you can't simply say:

> "Apply DSR to whatever metric we like."

DSR is specifically constructed around Sharpe-type statistics.

### PBO

PBO is different.

It is fundamentally about:

> **How likely is it that the in-sample winner is overfit / fails out of sample?**

It isn't simply a generic numerical haircut that you subtract from every metric.

So I'd change your wording from:

> Multiple-testing correction (Deflated Sharpe / PBO)

to something more precise:

> **Data-snooping / selection-bias assessment appropriate to the evaluation statistic (e.g. DSR, PBO, Reality Check/SPA).**

That matters because otherwise your architecture could accidentally turn:

```text
DSR
PBO
Reality Check
SPA
```

into four interchangeable "penalties."

They're not.

---

# 3. Calibration + Discrimination

This is your **best improvement**.

```text
             ┌──────────────┐
             │ Calibration  │
             └──────────────┘
                    +
             ┌──────────────┐
             │Discrimination│
             └──────────────┘
```

### Verdict: ✅ Strong

The previous architecture said:

> Add calibration.

Your revised architecture says:

> Calibration is not enough. We also need discrimination.

That's much more rigorous.

### Calibration asks:

> When the system says 70%, does the event actually happen around 70% of the time?

### Discrimination asks:

> Can the system distinguish better opportunities from worse opportunities?

A model predicting:

```text
50% for everything
```

could be perfectly calibrated but useless for selecting trades.

So:

```text
Calibration ≠ Edge
```

and:

```text
Discrimination ≠ Calibration
```

You need both.

---

# 4. But I would add one word: **Economic edge**

This is the second modification I'd make.

"Discrimination" by itself still isn't the final definition of trading edge.

You ultimately care about:

$$
E[Net\ Return \mid signal/context] > benchmark
$$

after:

* fees
* spread
* slippage
* execution
* position sizing
* realistic option fills

Therefore I'd conceptualize this branch as:

```text
Calibration
      +
Discrimination
      +
Economic / Trading Edge
```

Discrimination tells you whether the model ranks opportunities meaningfully.

Economic evaluation tells you whether that ranking actually produces **positive tradable expectancy**.

This is especially important for your options-buying framework.

A model can discriminate very well but still produce negative P&L after costs.

---

# 5. Permutation / Reality Check / SPA

You have:

```text
Calibration
Discrimination
       ↓
Permutation / Reality Check / SPA
```

### Verdict: 🟢 Conceptually very strong

This is better than the previous architecture because you've explicitly placed a **data-snooping-aware statistical test** after the model evaluation.

But there's an extremely important implementation detail:

### You must reproduce the search inside the null experiment.

Suppose you tested:

```text
10,000 configurations
```

and found:

```text
best Sharpe = 2.5
```

Your null experiment cannot simply test one fixed strategy against shuffled data.

It needs to approximate:

```text
Randomized dataset
       ↓
10,000 configurations
       ↓
select the best
       ↓
record best statistic
```

and repeat.

Otherwise you aren't answering:

> "Could my research process have found this result by chance?"

You're answering the weaker question:

> "Could this already-selected strategy have performed this well by chance?"

Those are very different.

This is exactly why your **trial accounting layer is so important**.

---

# 6. Huge caveat: don't blindly "shuffle labels" in market data

Your previous document suggested permutation/shuffling.

That needs care.

Financial time series are not generally iid.

You have:

* autocorrelation
* volatility clustering
* regime persistence
* temporal dependence
* overlapping observations
* serially correlated returns

So a naive:

```text
random.shuffle(labels)
```

can create an unrealistic null.

For time-series trading research, the null-generation method needs to preserve the relevant dependence structure where appropriate — e.g. block/bootstrap-style approaches or other time-series-specific null constructions.

So:

> **Permutation test = good idea.**
>
> **Naively shuffling market labels = not automatically valid.**

This is a significant implementation consideration.

---

# 7. Strict OOS

You have:

```text
Permutation / Reality Check / SPA
              ↓
         Strict OOS
```

### Verdict: ✅ Absolutely keep it.

But there is one conceptual requirement:

**The OOS dataset must actually remain untouched during research.**

If you:

```text
Train
 ↓
search
 ↓
inspect OOS
 ↓
change threshold
 ↓
inspect OOS again
 ↓
recalibrate
```

then:

```text
OOS
```

has silently become:

```text
research data
```

and you need another untouched OOS set.

So the strongest interpretation is:

```text
Development data
      ↓
Research/search
      ↓
Statistical correction
      ↓
LOCK
      ↓
Untouched OOS
```

No peeking.

---

# 8. Forward/live validation

### Verdict: ✅ Correct final layer.

This is important because even a strong OOS result is still historical evidence.

Forward validation asks:

> Does the frozen system continue behaving correctly when nobody is allowed to modify it based on incoming results?

That's much closer to the actual deployment problem.

---

# 9. One thing I would change in your ordering

Your architecture currently implies:

```text
Trial ledger
↓
Multiple-testing correction
↓
Calibration/discrimination
↓
Reality Check
↓
OOS
```

I wouldn't interpret these as a rigid one-way statistical pipeline.

Some of these are **diagnostics**, some are **selection controls**, and some are **final inference**.

A better conceptual architecture is:

```text
                    RESEARCH / DEVELOPMENT
                           │
                           ▼
                    Trial Accounting
                           │
                           ▼
                Candidate Evaluation
                    ┌──────┴──────┐
                    ▼             ▼
               Calibration   Discrimination
                    │             │
                    └──────┬──────┘
                           ▼
                    Economic Edge
                           │
                           ▼
              Selection / Data-Snooping
              Assessment & Correction
              (DSR / PBO / RC / SPA etc.)
                           │
                           ▼
                    ─── LOCK ───
                           │
                           ▼
                    STRICT OOS
                           │
                           ▼
                 ─── DEPLOY ───
                           │
                           ▼
                FORWARD VALIDATION
```

That's how I'd actually think about the system.

---

# 10. The most important addition: recalibration can create leakage

You correctly said:

> "re-triggers every time you add a regrouping or recalibration step"

### ✅ Excellent.

But there's an even deeper consequence.

Suppose you do:

```text
Model says 70%
       ↓
actual = 60%
       ↓
recalibrate 70% → 63%
       ↓
test again
       ↓
recalibrate again
       ↓
test again
```

Every adjustment is another opportunity to fit historical noise.

So your architecture should treat:

```text
model training
+
parameter tuning
+
threshold tuning
+
regrouping
+
probability recalibration
+
regime definition
+
feature selection
+
trade filtering
```

as part of the **research search process**.

That's a very strong principle.

---

# 11. Is your revised architecture stronger than my previous one?

### Yes.

My previous version was:

```text
Trial Ledger
→ Multiple-testing correction
→ Permutation / Reality Check
→ Calibration
→ OOS
→ Forward validation
```

Your revised version improves it to:

```text
Trial Ledger
→ Selection-bias accounting
→ Calibration + Discrimination
→ Statistical significance / Reality Check
→ OOS
→ Forward validation
```

The critical improvement is:

> **You are no longer treating "calibration" as evidence of edge by itself.**

That's exactly right.

---

# 12. But I would make your final architecture slightly different

After the audit, **this is the version I would sign off on**:

```text
                    ┌─────────────────────────┐
                    │   COMPLETE TRIAL LEDGER │
                    │                         │
                    │ Parameters              │
                    │ Features                │
                    │ Thresholds              │
                    │ Regime definitions      │
                    │ Groupings               │
                    │ Recalibrations          │
                    │ Model/scorer variants   │
                    └────────────┬────────────┘
                                 │
                                 ▼
                       CANDIDATE EVALUATION
                                 │
                    ┌────────────┼────────────┐
                    ▼            ▼            ▼
              Calibration  Discrimination  Economic Edge
                    │            │            │
                    └────────────┼────────────┘
                                 ▼
                    DATA-SNOOPING / SELECTION
                         INFERENCE LAYER
                    ┌────────────┼────────────┐
                    │            │            │
                   DSR          PBO       RC / SPA
                    │            │            │
                    └────────────┼────────────┘
                                 ▼
                     STRICTLY LOCKED OOS
                                 │
                                 ▼
                       FORWARD / LIVE TEST
                                 │
                                 ▼
                     DEPLOYMENT MONITORING
```

With two rules underneath it:

```text
RULE 1:
Any data-informed research decision counts toward
the search history.

RULE 2:
Once OOS is exposed to decision-making, it is no
longer OOS.
```

---

# Final judgment

**Your revised architecture is genuinely stronger than the previous architecture.**

I'd classify it:

**~9.2/10 conceptually.**

The three corrections I would make are:

1. **Don't call DSR/PBO generic interchangeable "multiple-testing corrections."** They have different purposes and assumptions.
2. **Add Economic Edge/Expected Value explicitly beside calibration and discrimination.**
3. **Make the Reality Check/SPA null preserve relevant time-series structure and reproduce the selection/search process.**

With those changes, I would consider this a **much more statistically defensible research architecture**.

And yes — your instinct to make **trial accounting continuous rather than a one-time gate** is particularly important. A new regrouping, threshold, regime definition, recalibration, or model variant can reopen the multiple-testing problem. That's one of the strongest parts of your revision.




---




# My Verdict on Above Markdown Blocks

**Verdict: the two rules are solid and correct. The diagram and the self-graded 9.2/10 are not fully consistent with each other — three issues:**

**1. Correction #1 identifies a real flaw the diagram still has, uncorrected.**
DSR, PBO, and RC/SPA are drawn as three symmetric boxes merging into one arrow — structurally identical treatment to the Calibration/Discrimination/EV row above it. That's the exact interchangeable-siblings framing correction #1 objects to. They don't share inputs:
- **DSR** needs the distribution of trial Sharpe ratios (or trial count + return moments) — corrects a significance threshold.
- **PBO** needs actual IS/OOS partition splits (combinatorial CV) — outputs a probability of overfitting, not a p-value.
- **RC/SPA** needs the full return series of every candidate, bootstrap-resampled — outputs a test of superior predictive ability net of search.

A 9.2 for a diagram that still visually commits the error the score's own footnotes flag is internally inconsistent. Either the score should be lower, or the box should change (e.g., three inputs feeding distinct sub-tests, not one merged lane).

**2. Correction #2 appears to already be satisfied.**
The diagram already shows Economic Edge as a third sibling next to Calibration and Discrimination. Listing "add EV" as an outstanding correction suggests the judgment text was written against an earlier version and never reconciled with the diagram it's supposedly scoring. Worth checking which one is actually current before trusting either.

**3. Correction #3 is the most substantively important one, and it's correct.**
Naive iid bootstrap under RC/SPA is invalid for option-strategy returns with serial dependence (overlapping positions, regime persistence) — you need a block/stationary bootstrap (Politis–Romano) that preserves the dependency structure, and the resampling has to replay the actual selection procedure, not just resample the winning strategy's returns in isolation. This is a genuine, non-cosmetic fix, correctly flagged.

**4. Missing — not caught by any of the three corrections: no feedback loop.**
The diagram terminates at Deployment Monitoring. But Rule 1 says any data-informed decision counts toward search history — so a live recalibration after 3 months of underperformance is a new trial by the diagram's own logic, yet there's no arrow back to the Trial Ledger. As drawn, the architecture is airtight until deployment, then quietly exempts itself from its own rule. That's the single largest structural gap, bigger than any of the three listed.

**5. Domain gaps not yet in the pipeline at all** (relevant to BuyerEdgeStrategy specifically):
- Economic Edge has no explicit slippage/spread/brokerage term — NSE option spreads on BANKNIFTY/NIFTY can erode a statistically real edge into a negative net one.
- No check that the locked OOS window doesn't straddle a structural break (NSE has changed weekly expiry days and contract sizes before) — an OOS failure could mean overfitting or could mean the regime changed under it; the diagram can't currently tell those apart.
- PBO's CSCV needs enough sub-samples to partition meaningfully — worth confirming trade count per config supports it before trusting the PBO output rather than treating it as decorative.

**My score:** this is a genuinely strong architecture — better than the previous version, and the continuous trial-accounting instinct is the best part of it, unchanged from last review. But as literally drawn, I'd put it around 7.5–8/10, not 9.2 — the gap is the unfixed sibling-box problem (item 1), the stale correction (item 2), and the missing monitoring→ledger feedback loop (item 4). Fix those and it's a 9+.
